Cantabio Pharmaceuticals, Inc. operates as a pre-clinical drug development company focused on developing therapeutics for neurodegenerative and metabolic diseases. The company develops drug candidates ...
Nasdaq Analyst Research provides analyst research for ratings consensus and a summary of stock price targets. Analysts evaluate the stock’s expected performance in a given time period based on their ...
Find the latest Cantabio Pharmaceuticals, Inc. (CTBO) stock quote, history, news and other vital information to help you with your stock trading and investing.
Insider Trading information for NDAQ is derived from Forms 3 and 4 filings filed with the U.S. Securities and Exchange Commission (SEC). Please Note:An FPI is exempt of filing insider holdings with ...
Cantabio Pharmaceuticals, Inc. (CTBO) key stats comparison: compare with other stocks by metrics: valuation, growth, profitability, momentum, EPS revisions, dividends ...
At close: 8 September at 20:00:00 GMT-4 ...
At close: 7 October at 4:00 pm GMT-4 ...
At close: 26 November at 4:00:00 pm GMT-5 ...
Research reports are not currently available for CTBO.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results